[ACRX] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
02-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 156.98%
YoY- 655.44%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 4,531 3,025 1,730 15,428 1,924 181 226 639.35%
PBT -11,092 -10,979 -10,558 5,841 -8,896 -10,026 -13,818 -13.63%
Tax -2,083 2 -12 772 777 806 -1,218 43.05%
NP -11,092 -10,981 -10,546 5,069 -8,896 -10,026 -13,818 -13.63%
Tax Rate - - - -13.22% - - - -
Total Cost 15,623 14,006 12,276 10,359 10,820 10,207 14,044 7.36%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -244.80 -363.01 -609.60 32.86 -462.37 -5,539.23 -6,114.16 -88.31%
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -4.90 -4.85 -4.66 2.20 -4.01 -4.57 -6.30 -15.43%
EPS Diluted -4.90 -4.85 -4.66 2.20 -4.01 -4.51 -6.22 -14.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.